We are live on ! Find out more
GEA

Glen Eagle Advisors Portfolio holdings

AUM $714M
1-Year Est. Return 18.87%
This Fund
S&P 500
This Quarter Est. Return
+19.04%
1 Year Est. Return
+18.87%
3 Year Est. Return
+62.99%
5 Year Est. Return
+76.32%
10 Year Est. Return
AUM
$195M
AUM Growth
+$52.2M
Cap. Flow
+$26.1M
Cap. Flow %
13.41%
Top 10 Hldgs %
33.87%
Holding
952
New
99
Increased
260
Reduced
167
Closed
51

Sector Composition

Rank Sector Weight
1 Healthcare 12.63%
2 Technology 12.47%
3 Financials 5.38%
4 Consumer Discretionary 5.26%
5 Communication Services 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIG icon
776
American International
AIG
$41.9B
$1.56K ﹤0.01%
50
CC icon
777
Chemours
CC
$2.59B
$1.53K ﹤0.01%
100
SWK icon
778
Stanley Black & Decker
SWK
$14.2B
$1.53K ﹤0.01%
+11
New +$1.33K
FCG icon
779
First Trust Natural Gas ETF
FCG
$632M
$1.5K ﹤0.01%
200
+100
+100% +$715
WEC icon
780
WEC Energy
WEC
$37.7B
$1.49K ﹤0.01%
17
NVCR icon
781
NovoCure
NVCR
$2.04B
$1.48K ﹤0.01%
+25
New +$1.64K
AVXL icon
782
Anavex Life Sciences
AVXL
$222M
$1.48K ﹤0.01%
300
SPTM icon
783
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.5B
$1.47K ﹤0.01%
39
-192
-83% -$6.87K
HRTX icon
784
Heron Therapeutics
HRTX
$86.3M
$1.47K ﹤0.01%
+100
New +$1.64K
GTIP icon
785
Goldman Sachs Access Inflation Protected USD Bond ETF
GTIP
$292M
$1.44K ﹤0.01%
26
VMBS icon
786
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
$1.41K ﹤0.01%
26
VCEL icon
787
Vericel Corp
VCEL
$2.3B
$1.38K ﹤0.01%
100
PFFD icon
788
Global X US Preferred ETF
PFFD
$2.13B
$1.34K ﹤0.01%
+57
New +$1.33K
FNDF icon
789
Schwab Fundamental International Large Company Index ETF
FNDF
$24.3B
$1.33K ﹤0.01%
56
BTAI icon
790
BioXcel Therapeutics
BTAI
$26.2M
$1.32K ﹤0.01%
+2
New +$1.3K
LDUR icon
791
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.36B
$1.32K ﹤0.01%
13
-81
-86% -$8.12K
XLRE icon
792
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.69B
$1.29K ﹤0.01%
37
AEP icon
793
American Electric Power
AEP
$73.7B
$1.27K ﹤0.01%
16
CNC icon
794
Centene
CNC
$31.3B
$1.27K ﹤0.01%
+20
New +$1.3K
VYGR icon
795
Voyager Therapeutics
VYGR
$187M
$1.26K ﹤0.01%
100
BLD
796
DELISTED
TopBuild
BLD
$1.25K ﹤0.01%
11
MED icon
797
Medifast
MED
$108M
$1.25K ﹤0.01%
9
DNLI icon
798
Denali Therapeutics
DNLI
$3.67B
$1.21K ﹤0.01%
50
FUL icon
799
H.B. Fuller
FUL
$3B
$1.2K ﹤0.01%
+27
New +$980
VYX icon
800
NCR Voyix
VYX
$1.06B
$1.18K ﹤0.01%
+111
New +$1.27K

Similar funds

Glen Eagle Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Glen Eagle Advisors held 952 positions worth $195M, up 37% from $143M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Glen Eagle Advisors deployed $26.1M of net new capital in Q2 2020, opening 99 new positions and adding to 260 existing holdings. Its largest new stake was FT Vest US Equity Deep Buffer ETF February: 24,961 shares worth $745K.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 7.3% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, an estimated $664K trimmed.

  • Glen Eagle Advisors's largest Q2 2020 buy was FT Vest US Equity Deep Buffer ETF February: 24,961 shares worth $745K.
  • Glen Eagle Advisors added most to Johnson & Johnson in Q2 2020, an estimated $11.9M increase.
  • Glen Eagle Advisors's biggest Q2 2020 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $664K.
  • Glen Eagle Advisors fully exited Raytheon Company in Q2 2020, selling an estimated $144K.
  • Glen Eagle Advisors's ten largest holdings make up 34% of its $195M portfolio in Q2 2020.
  • Glen Eagle Advisors opened 99 new positions and closed 51 in Q2 2020.
  • Glen Eagle Advisors's portfolio value rose 37% quarter-over-quarter to $195M.

Based on Glen Eagle Advisors's 13F filing for Q2 2020, filed 13 Aug 2024.